Helix BioMedix Inc. (OTCMKTS:HXBM) Shares Shorted: Short Interest Down 57.4% in September

Helix BioMedix Inc. (OTCMKTS:HXBM – Get Free Report) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totaling 87 shares, a drop of 57.4% from the August 31st total of 204 shares. Based on an average daily volume of 901 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the shares of the company are sold short.

Helix BioMedix Stock Performance

OTCMKTS HXBM opened at $4.40 on Wednesday. The company has a 50 day moving average of $3.21 and a 200-day moving average of $2.09. Helix BioMedix has a 1-year low of $1.00 and a 1-year high of $6.50.

Helix BioMedix Company Profile

(Get Free Report)

Helix BioMedix, Inc is a biotechnology company focused on the discovery, development and commercialization of bioactive peptides for personal-care, cosmetic and related life-science applications. Its work centers on peptides designed to support skin health and appearance, including products used in anti-aging, skin-repair and antimicrobial formulations.

The company develops proprietary peptide ingredients and licenses or supplies them to manufacturers and formulators for use in skincare and other topical products.

Further Reading

• Five stocks we like better than Helix BioMedix
• The Bull Case for Amprius Technologies Just Got Stronger
• CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
• CoreWeave Comes With Risks: Analysts Split on What Matters Most
• Bottlenecking the Future: TSMC Prices Out the Competition